Israeli medtech startup company CLT has set up a joint venture with a Dutch medical institute to develop and commercialize an arrhythmia-detecting drug pump combined with a unique drug, for automatic and immediate treatment of emerging atrial fibrillation (AF).
The Israeli company will set up the new venture Closed Loop Therapies (CLT) BV with Erasmus University Medical Center, a highly prominent medical institute based in Rotterdam.
AF, the most common cardiac arrhythmia, causes morbidity, mortality, decreased quality of life and considerable healthcare expenses. Existing treatments, whether electrical, surgical or pharmacological, have proven largely inadequate due to limited efficacy and/or potential for adverse effects. The system is based on a breakthrough discovery by two of the founders of CLT, Professor Eli Ovsyshcher of Ben Gurion University and Dr Ilya Fleidervish of the Hebrew University.
Lire la suite »
anti boycott israel blog: fibrillation atriale
Source: ISRAEL21c
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire